-
公开(公告)号:US10668167B2
公开(公告)日:2020-06-02
申请号:US16408602
申请日:2019-05-10
Applicant: AbbVie Inc.
Inventor: Michael J. McPherson , Adrian D. Hobson , Martin E. Hayes , Christopher C. Marvin , Diana Schmidt , Wendy Waegell , Christian Goess , Jason Z. Oh , Axel Hernandez, Jr. , John T. Randolph
Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
-
公开(公告)号:US20220354959A1
公开(公告)日:2022-11-10
申请号:US17318723
申请日:2021-05-12
Applicant: AbbVie Inc.
Inventor: Michael J. McPherson , Adrian D. Hobson , Martin E. Hayes , Christopher C. Marvin , Diana Schmidt , Wendy Waegell , Christian Goess , Jason Z. Oh , Axel Hernandez, Jr. , John T. Randolph
Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
-
公开(公告)号:US20220265842A1
公开(公告)日:2022-08-25
申请号:US16768616
申请日:2018-11-29
Applicant: AbbVie Inc.
Inventor: Adrian D. Hobson , Jason Z. Oh , Michael J. McPherson , Wendy Waegell , Shaughn H. Bryant , Axel Hernandez, Jr. , Claire L. Ihle , Christopher C. Marvin , Olivia A. Perng , Ling C. Santora , Lu Wang , Lu Wang
Abstract: Provided herein are anti-CD40 antibody drug conjugates comprising a radical of Formula (I), wherein R1, R2, and R3 are as defined herein. Further provided are anti-CD40 antibody drug conjugates of Formula (II), wherein Z, R, AA1, AA2, AA3, m, p, q, n, w, R1, R2, and R3 are as defined herein. Further provided are pharmaceutical compositions and kits thereof, and methods of using same.
-
公开(公告)号:US20200338208A1
公开(公告)日:2020-10-29
申请号:US16850866
申请日:2020-04-16
Applicant: AbbVie Inc.
Inventor: Michael J. McPherson , Adrian D. Hobson , Martin E. Hayes , Christopher C. Marvin , Diana Schmidt , Wendy Waegell , Christian Goess , Jason Z. Oh , Axel Hernandez, JR. , John T. Randolph
Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
-
-
-